Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 94 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hemorrhagic Stroke Clear all

Conditions: Ischemic Stroke, Hemorrhagic Stroke, Traumatic Brain Injury
Interventions: Lateral Flow Device; Device
Lead sponsor: Justin Fraser; Other
Eligibility: 21 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Hemorrhagic Stroke
Interventions: In-patient and out-patient electronic health record alert; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: MRI scans with non heme iron levels; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 85 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Brain Injury, Central Nervous System Degenerative Disorder, Central Nervous System Infectious Disorder, Central Nervous System Vascular Malformation, Hemorrhagic Cerebrovascular Accident, Ischemic Cerebrovascular Accident, Primary Brain Neoplasm, Brain Cancer, Brain Tumors
Interventions: Ferumoxytol, Tissue Analysis, Magnetic Resonance Imaging; Drug · Other · Procedure
Lead sponsor: Michael Iv; Other
Eligibility: 2 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Stroke, Neurologic Diseases, General
Interventions: NC-758 (Anti amyloidotic [Aß] agent); Drug
Lead sponsor: Bellus Health Inc. - a GSK company; Industry
Eligibility: 55 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 5
States / cities: Lexington, Kentucky • Boston, Massachusetts • New York, New York + 2 more

Conditions: Sars-CoV2, Severe Neurologic Injury, Ischemic Stroke, Hemorrhagic Stroke, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Traumatic Brain Injury, Status Epilepticus
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Ischemic Stroke, Hemorrhagic Stroke
Interventions: COMPASS, Stroke education; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 50 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Stroke Hemorrhagic
Interventions: fMRI; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 22 Years to 80 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hemorrhagic Stroke, Hemiparesis
Interventions: dual transcranial direct current stimulation; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hemorrhagic Stroke, Intracerebral, Cerebral Cavernous Malformation
Interventions: CCM Hemorrhagic Panel; Diagnostic Test
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 10 Years to 78 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Blood Pressure, Stroke, Ischemic, Stroke Hemorrhagic
Interventions: Integrated Telehealth After Stroke Care, Usual post-stroke follow-up care; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Ischemic Stroke
Interventions: Acetylcysteine, Dextrose in Water; Drug
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Torrance, California

Conditions: Brain Injury, Ischemic Stroke, Hemorrhagic Stroke
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Intracerebral Hemorrhage
Interventions: Recombinant Factor VIIa, Biological/Vaccine: Placebo; Biological
Lead sponsor: Joseph Broderick, MD; Other
Eligibility: 18 Years to 80 Years
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 49
States / cities: Birmingham, Alabama • Baldwin Park, California • Burlingame, California + 39 more

Conditions: Stroke, Acute, Ischemic Stroke, Hemorrhagic Stroke, Mortality, Morbidity
Interventions: Minocycline; Drug
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Stroke Hemorrhagic, Depression
Interventions: Fluoxetine, Placebo; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 85 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hemiparesis, Neonatal Stroke, Ischemic Stroke, Hemorrhagic Stroke, Thrombotic Stroke
Interventions: Transcranial Magnetic Stimulation, Sham Magnetic Stimulation; Device
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 6 Years to 18 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Columbus, Ohio

Conditions: Ischemic Stroke, Ischaemic Stroke With Coma, Intracerebral Hemorrhage, Hemorrhagic Stroke
Interventions: Decision Aid; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: New Haven, Connecticut • Worcester, Massachusetts

Conditions: Intracerebral Hemorrhage
Interventions: Recombinant Activated Factor VII (rFVIIa), Placebo; Biological
Lead sponsor: Joseph Broderick, MD; Other
Eligibility: 18 Years to 80 Years
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 51
States / cities: Birmingham, Alabama • Phoenix, Arizona • Baldwin Park, California + 42 more

Conditions: Stroke Hemorrhagic
Interventions: Surgical management, Medical Management; Procedure · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 24
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Palo Alto, California + 19 more

Conditions: Acute Stroke, Acute Ischemic Stroke, Ischemic Stroke, Hemorrhagic Stroke
Interventions: Serum and Urine measurement of cytokines.; Other
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Stroke
Interventions: Not listed
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 1,260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2025
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Stroke, Ischemic, Stroke Hemorrhagic, Fever, Seizures, Metabolic Encephalopathy
Interventions: Transnasal Thermal Regulating Device; Device
Lead sponsor: CoolTech LLC; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Houston, Texas

Conditions: Acute Coronary Syndrome
Interventions: Apolipoprotein A-I [human] (apoA-I), Placebo; Biological · Other
Lead sponsor: CSL Behring; Industry
Eligibility: 18 Years and older
Enrollment: 18,226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 202
States / cities: Alexander City, Alabama • Birmingham, Alabama • Huntsville, Alabama + 175 more

Search by objective public record fields.

Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)

Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke

Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy

COVID-19 Brain Injury

A Novel Transition Program to Reduce Disability After Stroke

Functional MRI and DTI Analysis of Post VNS Therapy Rehab Changes

Dual Transcranial Direct Current Stimulation (dTDCS)-Enhanced Therapy After Hemorrhagic Strokes and VEGF

CCM Blood Biomarker Validation Study

Integrated Telehealth After Stroke Care

Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke

Estimating Volume Using LiDCO

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Maimonides Minocycline in Stroke Study

Poststroke Depression in Hemorrhagic Stroke

Transcranial Magnetic Stimulation in Children With Stroke

Decision Aid Feasibility Trial for Families of Critically Ill Stroke Patients

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

Cytokine Registry Database of Stroke Patients

Genetic and Environmental Risk Factors for Hemorrhagic Stroke-GERFHS III

Transnasal Induction of Normothermia in Febrile Stroke Patients

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome